August 2018 FDA Recall Drug by Sca Pharmaceuticals, Inc.
D-1189-2018 - Presence of Precipitate

This Class I drug recall was voluntarily initiated by Sca Pharmaceuticals, Inc. on August 27, 2018 for the product Drug. The FDA reported the reason for recall as presence of precipitate. The product was distributed in Three hospitals in DC, VA, CT and the recall is currently terminated.

Recall Number: D-1189-2018

Reason for Recall
Presence of Precipitate: Customer complaint for visible precipitate in product believed to be the active ingredient furosemide.
Initiated
08-27-2018
Reported
09-19-2018
Quantity
1384 bags

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
SCA Pharmaceuticals, Inc.
Three hospitals in DC, VA, CT
Furosemide 100 mg added to 0.9% Sodium Chloride 100 mL Injection, 100 mL Single Dose Container bag, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct., Little Rock, AR 72205, 877.550.5059, barcode 70004063032.

Batch or Lot Expiration Information

Lot# Lots: 20180711@18, BUD: 10/3/2018; 20180712@19, 20180712@21, 20180712@24 BUD: 10/4/2018; 20180713@19, BUD: 10/5/2018; 20180727@21, BUD: 10/19/2018; 20180803@20, BUD: 10/26/2018